“Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease ”. Vascular and Endovascular Review, vol. 8, no. 9s, Nov. 2025, pp. 230-6, https://doi.org/10.64149/J.Ver.8.9s.230-236.